scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Morad Remy Muhsin-Sharafaldine | Q118959582 |
P2093 | author name string | Alexander D McLellan | |
P2860 | cites work | Caspase-mediated cleavage and activation of LIM-kinase 1 and its role in apoptotic membrane blebbing. | Q44930829 |
Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. | Q45073094 | ||
Effect of tamoxifen on measurements of hemostasis in healthy women | Q45878122 | ||
Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles. | Q51317118 | ||
Antiapoptotic effect of coagulation factor VIIa. | Q51837430 | ||
Mitotic catastrophe: a mechanism for avoiding genomic instability. | Q52610466 | ||
Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity. | Q52614705 | ||
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. | Q52935183 | ||
The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles. | Q53250751 | ||
Circulating procoagulant microparticles in cancer patients. | Q53292843 | ||
Caspases find a new place to hide. | Q53338897 | ||
Calpain activation in plasma membrane bleb formation during tert-butyl hydroperoxide-induced rat hepatocyte injury. | Q54021698 | ||
CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. | Q55053710 | ||
Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. | Q55466614 | ||
Exfoliation of membrane ecto-enzymes in the form of micro-vesicles | Q55490241 | ||
Prognosis of Cancers Associated with Venous Thromboembolism | Q57301047 | ||
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score | Q57758028 | ||
Apoptosis: caspases orchestrate the ROCK `n' bleb | Q57910004 | ||
Tissue factor, thrombin, and cancer | Q35217277 | ||
Tetraspanin Proteins Mediate Cellular Penetration, Invasion, and Fusion Events and Define a Novel Type of Membrane Microdomain | Q35564822 | ||
CD169+ macrophages are sufficient for priming of CTLs with specificities left out by cross-priming dendritic cells | Q35567056 | ||
Improved characterization of EV preparations based on protein to lipid ratio and lipid properties | Q35583785 | ||
Histopathological patterns of melanoma metastases in sentinel lymph nodes | Q35587301 | ||
T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection | Q35753066 | ||
Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells | Q35756979 | ||
Tumorigenic potential of extracellular matrix metalloproteinase inducer | Q35842240 | ||
Pathways of apoptotic and non-apoptotic death in tumour cells | Q35852309 | ||
Paracrine induction of endothelium by tumor exosomes. | Q35862798 | ||
The Trojan exosome hypothesis | Q35976953 | ||
Extracellular vesicles from Paracoccidioides pathogenic species transport polysaccharide and expose ligands for DC-SIGN receptors. | Q36099158 | ||
Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures | Q36139088 | ||
Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus | Q36228965 | ||
Identification of a conserved glycan signature for microvesicles | Q36237543 | ||
A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. | Q36255171 | ||
Lectin-like oxidized low-density lipoprotein receptor 1 mediates phagocytosis of aged/apoptotic cells in endothelial cells | Q36265106 | ||
Apoptotic membrane blebbing is regulated by myosin light chain phosphorylation | Q36274919 | ||
Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration | Q36293380 | ||
MicroRNAs are exported from malignant cells in customized particles | Q36305641 | ||
Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions | Q36305646 | ||
Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease | Q36355607 | ||
Chemotherapy-induced thrombosis | Q36358511 | ||
Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease | Q36375982 | ||
Phosphatidylserine (PS) induces PS receptor-mediated macropinocytosis and promotes clearance of apoptotic cells | Q36380062 | ||
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy | Q36558024 | ||
Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects | Q36616153 | ||
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration | Q36621701 | ||
Phospholipid flippases | Q36665864 | ||
Extracellular vesicle isolation and characterization: toward clinical application | Q36737951 | ||
Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory | Q36796664 | ||
Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. | Q36821101 | ||
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation | Q36835483 | ||
The metastatic niche: adapting the foreign soil | Q36928869 | ||
Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. | Q46033090 | ||
Galectin-5 is bound onto the surface of rat reticulocyte exosomes and modulates vesicle uptake by macrophages | Q46219107 | ||
In vivo kinetic biodistribution of nano-sized outer membrane vesicles derived from bacteria | Q46842239 | ||
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group | Q46859424 | ||
Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis | Q46954138 | ||
Resolvins suppress tumor growth and enhance cancer therapy. | Q47225724 | ||
Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study | Q47772034 | ||
The biological significance of the thromboplastic protein of blood. | Q47807987 | ||
Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. | Q47866335 | ||
Glycan profiling analysis using evanescent-field fluorescence-assisted lectin array: Importance of sugar recognition for cellular uptake of exosomes from mesenchymal stem cells | Q47872628 | ||
Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes. | Q47904335 | ||
Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells | Q47915872 | ||
MLKL, the Protein that Mediates Necroptosis, Also Regulates Endosomal Trafficking and Extracellular Vesicle Generation | Q47969532 | ||
Circulating endothelial microparticles in acute ischemic stroke: a link to severity, lesion volume and outcome | Q48536084 | ||
Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study | Q48661559 | ||
Xk-related protein 8 and CED-8 promote phosphatidylserine exposure in apoptotic cells | Q24307778 | ||
Calcium-dependent phospholipid scrambling by TMEM16F | Q24308774 | ||
Molecular cloning of human plasma membrane phospholipid scramblase. A protein mediating transbilayer movement of plasma membrane phospholipids | Q24316767 | ||
Caspases: the executioners of apoptosis | Q24530218 | ||
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
B lymphocytes secrete antigen-presenting vesicles | Q24678522 | ||
Apoptosis, oncosis, and necrosis. An overview of cell death | Q24684007 | ||
Deciphering the plasma membrane hallmarks of apoptotic cells: phosphatidylserine transverse redistribution and calcium entry | Q24794159 | ||
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial | Q24801506 | ||
Regulation of immune responses by extracellular vesicles | Q27006748 | ||
How apoptotic cells aid in the removal of their own cold dead bodies | Q27026126 | ||
Subcapsular sinus macrophage fragmentation and CD169+ bleb acquisition by closely associated IL-17-committed innate-like lymphocytes | Q27301739 | ||
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes | Q27317206 | ||
Wound repair: toward understanding and integration of single-cell and multicellular wound responses | Q36929762 | ||
Membrane protected apoptotic trophoblast microparticles contain nucleic acids: relevance to preeclampsia | Q37061065 | ||
Characterization of PKD protein-positive exosome-like vesicles | Q37086680 | ||
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients | Q37169096 | ||
Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies | Q37179972 | ||
Chemotherapy-induced thrombosis: a role for microparticles and tissue factor? | Q37223520 | ||
HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin. | Q37267861 | ||
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis | Q37341182 | ||
Tetraspanins: push and pull in suppressing and promoting metastasis | Q37349647 | ||
Alternatively spliced tissue factor induces angiogenesis through integrin ligation. | Q37429007 | ||
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. | Q37438142 | ||
Chemotherapy-associated thrombosis. | Q37450976 | ||
Exosome release by primary B cells. | Q37524069 | ||
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis | Q37527786 | ||
Isolation of cell type-specific apoptotic bodies by fluorescence-activated cell sorting | Q37563470 | ||
Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse | Q37629486 | ||
Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance | Q37659828 | ||
CD169⁺ macrophages provide a niche promoting erythropoiesis under homeostasis and stress | Q37698517 | ||
Lectin microarrays for glycomic analysis. | Q37781366 | ||
Macropinocytosis: an endocytic pathway for internalising large gulps | Q37855532 | ||
Exosome secretion: molecular mechanisms and roles in immune responses | Q37885448 | ||
The relationship between tissue factor and cancer progression: insights from bench and bedside | Q37953890 | ||
Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation | Q38062551 | ||
Tumour and microparticle tissue factor expression and cancer thrombosis. | Q38067136 | ||
Extracellular vesicles as mediators of neuron-glia communication | Q38160219 | ||
Tetraspanin proteins promote multiple cancer stages | Q38186043 | ||
Tetraspanins in extracellular vesicle formation and function | Q38256370 | ||
Getting to know the extracellular vesicle glycome. | Q38293737 | ||
Molecular analysis of sialoside binding to sialoadhesin by NMR and site-directed mutagenesis | Q38323182 | ||
Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. | Q38335062 | ||
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study | Q38497226 | ||
An Apoptotic 'Eat Me' Signal: Phosphatidylserine Exposure. | Q38599462 | ||
ADP ribosylation factor 6 (Arf6) acts through FilGAP protein to down-regulate Rac protein and regulates plasma membrane blebbing | Q38608946 | ||
Melanoma growth and lymph node metastasis is independent of host CD169 expression | Q38709566 | ||
Horizontal transfer of RNA and proteins between cells by extracellular microvesicles: 14 years later | Q38760829 | ||
Extracellular vesicles and intercellular communication within the nervous system | Q38795618 | ||
Disassembly of the Dying: Mechanisms and Functions. | Q38959192 | ||
Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure | Q38987723 | ||
Methodological Guidelines to Study Extracellular Vesicles | Q39299869 | ||
Antigen localization controls T cell-mediated tumor immunity | Q39517776 | ||
Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses | Q39793551 | ||
CD147 impacts angiogenesis and metastasis formation. | Q39892358 | ||
Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members | Q40036677 | ||
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model | Q40049073 | ||
Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells | Q40068378 | ||
Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. | Q40452110 | ||
Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. | Q40503317 | ||
Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells--existence of a threshold | Q40653519 | ||
Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles | Q40801310 | ||
Dendritic cells acquire antigens from live cells for cross-presentation to CTL. | Q40822225 | ||
Autophagic and apoptotic types of programmed cell death exhibit different fates of cytoskeletal filaments | Q40895734 | ||
Involvement of FADD and caspase-8 signalling in detachment-induced apoptosis | Q40925076 | ||
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs | Q41057373 | ||
Vesicles associated with calcification in the matrix of epiphyseal cartilage | Q41112755 | ||
Tamoxifen induces TGF-beta 1 activity and apoptosis of human MCF-7 breast cancer cells in vitro | Q41208987 | ||
Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. | Q41485418 | ||
Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures | Q41607523 | ||
Procoagulant and immunogenic properties of melanoma exosomes, microvesicles and apoptotic vesicles. | Q41820280 | ||
CD169 mediates the capture of exosomes in spleen and lymph node. | Q41865373 | ||
Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. | Q41937849 | ||
Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes | Q42112142 | ||
Oncosomes - large and small: what are they, where they came from? | Q42390054 | ||
IgM promotes the clearance of small particles and apoptotic microparticles by macrophages | Q42702832 | ||
CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin | Q43566795 | ||
Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma | Q44200289 | ||
A genomic perspective on membrane compartment organization. | Q44883436 | ||
Histone chaperones in nucleosome assembly and human disease | Q34647041 | ||
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors | Q34787754 | ||
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway | Q34910947 | ||
The role of thrombospondin-1 in apoptosis | Q34937276 | ||
Microvesicles: messengers and mediators of tumor progression | Q34987500 | ||
Surface glycosylation profiles of urine extracellular vesicles | Q34999330 | ||
Chemotherapeutic approaches for targeting cell death pathways | Q35094229 | ||
ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles | Q35148002 | ||
Cellular microparticles: what are they bad or good for? | Q35181674 | ||
Segregation of RNA and separate packaging of DNA and RNA in apoptotic bodies during apoptosis | Q33181284 | ||
Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation | Q33379387 | ||
Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha | Q33421740 | ||
Venous thrombosis: a multicausal disease | Q33597786 | ||
Measurement of outward translocation of phospholipids across human erythrocyte membrane | Q33647778 | ||
Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications | Q33692926 | ||
Triggers, targets and treatments for thrombosis | Q33765444 | ||
Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection | Q33850807 | ||
Horizontal transfer of DNA by the uptake of apoptotic bodies. | Q33862992 | ||
Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model. | Q33892712 | ||
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming | Q33936302 | ||
Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. | Q33941102 | ||
Phagocytosis and clearance of apoptotic cells is mediated by MER. | Q33946282 | ||
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation | Q33956786 | ||
Cell biology. Eat me or die. | Q33974281 | ||
Cancer, thrombosis, and anticoagulants | Q33982456 | ||
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles | Q34026858 | ||
Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies | Q34035888 | ||
Caspases: key players in programmed cell death | Q34103392 | ||
Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses | Q34115645 | ||
Preparing the "soil": the premetastatic niche | Q34187595 | ||
Microparticles in cardiovascular diseases. | Q34221054 | ||
Death by design: apoptosis, necrosis and autophagy | Q34365753 | ||
Role of flippases, scramblases and transfer proteins in phosphatidylserine subcellular distribution | Q34441896 | ||
Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles | Q34455456 | ||
Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases | Q34463608 | ||
Processing of engulfed apoptotic bodies yields T cell epitopes | Q34464645 | ||
RETRACTED: Pregnancy-associated exosomes and their modulation of T cell signaling | Q34486229 | ||
SCS macrophages suppress melanoma by restricting tumor-derived vesicle-B cell interactions | Q34518758 | ||
Lymphatic dissemination of tumour cells and the formation of micrometastases | Q34571762 | ||
Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine | Q34614956 | ||
Tumor-released microvesicles as vehicles of immunosuppression. | Q34616014 | ||
Necrosis is an active and controlled form of programmed cell death. | Q34628706 | ||
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
Membrane scission by the ESCRT-III complex | Q27929846 | ||
alphavbeta5 integrin recruits the CrkII-Dock180-rac1 complex for phagocytosis of apoptotic cells | Q28142034 | ||
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS | Q28202269 | ||
Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing | Q28210013 | ||
Complexes of tetraspanins with integrins: more than meets the eye | Q28210099 | ||
Double-stranded DNA in exosomes: a novel biomarker in cancer detection | Q28237711 | ||
Non-equilibration of hydrostatic pressure in blebbing cells. | Q28251616 | ||
Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation | Q28254159 | ||
Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity | Q28255255 | ||
ExoCarta: A compendium of exosomal proteins and RNA | Q28260686 | ||
Calreticulin exposure dictates the immunogenicity of cancer cell death | Q28280438 | ||
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation | Q28344659 | ||
Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2 | Q28348328 | ||
Resolution of lung inflammation by CD44 | Q28506254 | ||
Phosphatidylserine receptor is required for clearance of apoptotic cells | Q28513214 | ||
Sialoglycoproteins and N-glycans from secreted exosomes of ovarian carcinoma cells | Q28535417 | ||
Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency | Q29032278 | ||
Caspases: enemies within | Q29547315 | ||
Exosomes: composition, biogenesis and function | Q29547721 | ||
Membrane vesicles as conveyors of immune responses | Q29547765 | ||
Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules | Q29614240 | ||
A role for ubiquitin in selective autophagy | Q29614499 | ||
Cellular senescence: when bad things happen to good cells | Q29615561 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
Ceramide triggers budding of exosome vesicles into multivesicular endosomes | Q29616811 | ||
Extracellular vesicles: exosomes, microvesicles, and friends | Q29618137 | ||
Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes | Q29619437 | ||
Unexpected link between an antibiotic, pannexin channels and apoptosis | Q30410630 | ||
Isolation and identification of potential urinary microparticle biomarkers of bladder cancer | Q30445880 | ||
A novel role for microtubules in apoptotic chromatin dynamics and cellular fragmentation | Q30478057 | ||
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease | Q30494070 | ||
CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes | Q30496134 | ||
ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion | Q30560783 | ||
Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. | Q30805170 | ||
Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER | Q30826764 | ||
Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro | Q31090085 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | cell | Q7868 |
apoptotic process | Q14599311 | ||
neoplasm | Q1216998 | ||
extracellular vesicle | Q21097485 | ||
P304 | page(s) | 957 | |
P577 | publication date | 2018-05-07 | |
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Tumor-Derived Apoptotic Vesicles: With Death They Do Part. | |
P478 | volume | 9 |
Q60961340 | A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis |
Q91707081 | Exosomes in cancer development, metastasis, and immunity |
Q92988727 | Glycan-Modified Apoptotic Melanoma-Derived Extracellular Vesicles as Antigen Source for Anti-Tumor Vaccination |
Q64086001 | Moving beyond size and phosphatidylserine exposure: evidence for a diversity of apoptotic cell-derived extracellular vesicles |
Q58738792 | Plasma Membrane Lipid Domains as Platforms for Vesicle Biogenesis and Shedding? |